Cargando…

Definitive Radiochemotherapy in Esophageal Cancer - A Single Institution Experience

BACKGROUND: Definitive radiochemotherapy is the preferred treatment option in patients with the cancer of the cervical esophagus and a viable treatment option in patients with the cancer of lower two thirds of the esophagus, who decline proposed surgical treatment. The purpose of the study was to ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anderluh, Franc, Toplak, Miha, Velenik, Vaneja, Oblak, Irena, Ermenc, Ajra Secerov, Peressutti, Ana Jeromen, But-Hadzic, Jasna, Vidmar, Marija Skoblar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884939/ https://www.ncbi.nlm.nih.gov/pubmed/31747382 http://dx.doi.org/10.2478/raon-2019-0054

Ejemplares similares

Preoperative treatment with radiochemotherapy for locally advanced gastroesophageal junction cancer and unresectable locally advanced gastric cancer
por: Ratosa, Ivica, et al.
Publicado: (2015)

Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma
por: Oblak, Irena, et al.
Publicado: (2014)

Results of postoperative radiochemotherapy of the patients with resectable gastroesophageal junction adenocarcinoma in Slovenia
por: Jeromen, Ana, et al.
Publicado: (2012)

The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin
por: Oblak, Irena, et al.
Publicado: (2016)

Induction Chemotherapy, Chemoradiotherapy and Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer - Long-term Results of Phase II OIGIT-01 Trial
por: Golo, Danijela, et al.
Publicado: (2018)

Total Neoadjuvant Treatment of Locally Advanced Rectal Cancer with High Risk Factors in Slovenia
por: Tuta, Mojca, et al.
Publicado: (2019)

Health-related Quality of Life Assessed by the EORTC QLQ-C30 Questionnaire in the General Slovenian Population
por: Velenik, Vaneja, et al.
Publicado: (2017)

Mesenteric ischemia after capecitabine treatment in rectal cancer and resultant short bowel syndrome is not an absolute contraindication for radical oncological treatment
por: Perpar, Ana, et al.
Publicado: (2015)

The correlation between the levels of tissue inhibitor of metalloproteinases 1 in plasma and tumour response and survival after preoperative radiochemotherapy in patients with rectal cancer
por: Oblak, Irena, et al.
Publicado: (2013)

Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer
por: Velenik, Vaneja, et al.
Publicado: (2010)

Cetuximab in preoperative treatment of rectal cancer – term outcome of the XERT trial
por: Velenik, Vaneja, et al.
Publicado: (2012)

Long term outcome after combined modality treatment for anal cancer
por: Oblak, Irena, et al.
Publicado: (2012)

The Role of MRI and PET/CT in Radiotherapy Target Volume Determination in Gastrointestinal Cancers—Review of the Literature
por: Secerov Ermenc, Ajra, et al.
Publicado: (2023)

Differences in plasma TIMP-1 levels between healthy people and patients with rectal cancer stage II or III
por: Oblak, Irena, et al.
Publicado: (2011)

Preoperative Intensity-modulated Chemoradiation Therapy with Simultaneous Integrated Boost in Rectal Cancer: 2-year Follow-up Results of Phase II Study
por: But-Hadzic, Jasna, et al.
Publicado: (2018)

Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study
por: Velenik, Vaneja, et al.
Publicado: (2011)

Preoperative Intensity-modulated Chemoradiotherapy with Simultaneous Integrated Boost in Rectal Cancer: Five-year Follow-up Results of a Phase II Study
por: But-Hadzic, Jasna, et al.
Publicado: (2021)

Post-treatment surveillance in colorectal cancer
por: Velenik, Vaneja
Publicado: (2010)

Stereotactic radiosurgery for patients with breast cancer brain oligometastases — molecular subtypes and clinical outcomes
por: Ratosa, Ivica, et al.
Publicado: (2021)

Glioblastoma in Patients over 70 Years of Age
por: Smrdel, Uros, et al.
Publicado: (2018)

A Retrospective Study on Radiotherapy and Radiochemotherapy in Esophageal Cancer
por: Kim, Chang-Min, et al.
Publicado: (1988)

The Value of FET PET/CT in Recurrent Glioma with a Different IDH Mutation Status: The Relationship between Imaging and Molecular Biomarkers
por: Skoblar Vidmar, Marija, et al.
Publicado: (2022)

Definition of an Normal Tissue Complication Probability Model for the Inner Ear in Definitive Radiochemotherapy of Nasopharynx Carcinoma
por: Peuker, Leonie, et al.
Publicado: (2022)

The Influence of the Distal Resection Margin Length on Local Recurrence and long- term Survival in Patients with Rectal Cancer after Chemoradiotherapy and Sphincter- Preserving Rectal Resection
por: Grosek, Jan, et al.
Publicado: (2016)

Laparoscopic insertion of pelvic tissue expander prior radiotherapy for sacral metastasis of alveolar maxillary rhabdomyosarcoma to prevent radiation enteritis
por: Omejc, Andrej, et al.
Publicado: (2021)

Radiochemotherapy
Publicado: (1998)

Adjuvant Radiochemotherapy versus Chemotherapy Alone for Gastric Cancer: Implications for Target Definition
por: Xu, Jing, et al.
Publicado: (2019)

Neoadjuvant versus definitive radiochemotherapy of locoregionally advanced oesophageal cancer—who benefits?
por: Schiffner, Christoph, et al.
Publicado: (2022)

Impact of Perioperative Treatment on Survival of Resectable Gastric Cancer Patients After D2 Lymphadenectomy: A Single European Centre Propensity Score Matching Analysis
por: Jagric, Tomaz, et al.
Publicado: (2019)

Influence of Concurrent Capecitabine Based Chemoradiotherapy with Bevacizumab on The Survival Rate, Late Toxicity and Health-related Quality of Life in Locally Advanced Rectal Cancer: a Prospective Phase II CRAB Trial
por: Velenik, Vaneja, et al.
Publicado: (2020)

Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure
por: Tuta, Mojca, et al.
Publicado: (2021)

Salvage radiotherapy in patients with local recurrent esophageal cancer after radical radiochemotherapy
por: Zhou, Zhi-guo, et al.
Publicado: (2015)

Salvage radiochemotherapy for lymph node recurrence after radical surgery of esophageal cancer
por: Zhou, Yi-Qin, et al.
Publicado: (2018)

Assessment of Salvage Surgery in Persistent Cervical Cancer after Definitive Radiochemotherapy: A Systematic Review
por: Conte, Carmine, et al.
Publicado: (2023)

Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration
por: Zottel, Alja, et al.
Publicado: (2020)

Cognitive functioning in a cohort of high-grade glioma patients
por: Skufca Smrdel, Andreja Cirila, et al.
Publicado: (2023)

Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy
por: Vacchelli, Erika, et al.
Publicado: (2015)

Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity
por: Paireder, Matthias, et al.
Publicado: (2020)

Comparison of the Therapeutic Effects of Iodine-125 Seed Implantation and Conventional Radiochemotherapy for Advanced Esophageal Cancer
por: Han, Lian-Qiang, et al.
Publicado: (2022)

Neck control after definitive radiochemotherapy without planned neck dissection in node-positive head and neck cancers
por: Jang, Na Young, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7i3g2654814di84shro19b97rd